These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23800539)

  • 1. A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria.
    Murungi LM; Kamuyu G; Lowe B; Bejon P; Theisen M; Kinyanjui SM; Marsh K; Osier FH
    Vaccine; 2013 Aug; 31(37):3936-42. PubMed ID: 23800539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria.
    Osier FH; Fegan G; Polley SD; Murungi L; Verra F; Tetteh KK; Lowe B; Mwangi T; Bull PC; Thomas AW; Cavanagh DR; McBride JS; Lanar DE; Mackinnon MJ; Conway DJ; Marsh K
    Infect Immun; 2008 May; 76(5):2240-8. PubMed ID: 18316390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics and role of antibodies to Plasmodium falciparum merozoite antigens in children living in two settings with differing malaria transmission intensity.
    Kangoye DT; Mensah VA; Murungi LM; Nkumama I; Nebie I; Marsh K; Cisse B; Bejon P; Osier FH; Sirima SB;
    Vaccine; 2016 Jan; 34(1):160-6. PubMed ID: 26541134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis.
    Fowkes FJ; Richards JS; Simpson JA; Beeson JG
    PLoS Med; 2010 Jan; 7(1):e1000218. PubMed ID: 20098724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of avidity maturation of merozoite antigen-specific antibodies with increasing exposure to Plasmodium falciparum amongst children and adults exposed to endemic malaria in Kenya.
    Ibison F; Olotu A; Muema DM; Mwacharo J; Ohuma E; Kimani D; Marsh K; Bejon P; Ndungu FM
    PLoS One; 2012; 7(12):e52939. PubMed ID: 23300828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmodium falciparum Protein Microarray Antibody Profiles Correlate With Protection From Symptomatic Malaria in Kenya.
    Dent AE; Nakajima R; Liang L; Baum E; Moormann AM; Sumba PO; Vulule J; Babineau D; Randall A; Davies DH; Felgner PL; Kazura JW
    J Infect Dis; 2015 Nov; 212(9):1429-38. PubMed ID: 25883384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquisition of antibodies against Plasmodium falciparum merozoites and malaria immunity in young children and the influence of age, force of infection, and magnitude of response.
    Stanisic DI; Fowkes FJ; Koinari M; Javati S; Lin E; Kiniboro B; Richards JS; Robinson LJ; Schofield L; Kazura JW; King CL; Zimmerman P; Felger I; Siba PM; Mueller I; Beeson JG
    Infect Immun; 2015 Feb; 83(2):646-60. PubMed ID: 25422270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High affinity antibodies to Plasmodium falciparum merozoite antigens are associated with protection from malaria.
    Reddy SB; Anders RF; Beeson JG; Färnert A; Kironde F; Berenzon SK; Wahlgren M; Linse S; Persson KE
    PLoS One; 2012; 7(2):e32242. PubMed ID: 22363818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Merozoite Surface Protein 1 from Plasmodium falciparum Is a Major Target of Opsonizing Antibodies in Individuals with Acquired Immunity against Malaria.
    Jäschke A; Coulibaly B; Remarque EJ; Bujard H; Epp C
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal analyses of immune responses to Plasmodium falciparum derived peptides corresponding to novel blood stage antigens in coastal Kenya.
    Agak GW; Bejon P; Fegan G; Gicheru N; Villard V; Kajava AV; Marsh K; Corradin G
    Vaccine; 2008 Apr; 26(16):1963-71. PubMed ID: 18342997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating individual exposure to malaria using local prevalence of malaria infection in the field.
    Olotu A; Fegan G; Wambua J; Nyangweso G; Ogada E; Drakeley C; Marsh K; Bejon P
    PLoS One; 2012; 7(3):e32929. PubMed ID: 22479349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria.
    Perraut R; Varela ML; Joos C; Diouf B; Sokhna C; Mbengue B; Tall A; Loucoubar C; Touré A; Mercereau-Puijalon O
    Vaccine; 2017 Dec; 35(48 Pt B):6720-6726. PubMed ID: 29042203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to Plasmodium falciparum erythrocyte-binding antigen-175 are associated with protection from clinical malaria.
    McCarra MB; Ayodo G; Sumba PO; Kazura JW; Moormann AM; Narum DL; John CC
    Pediatr Infect Dis J; 2011 Dec; 30(12):1037-42. PubMed ID: 21817955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of antibody responses to selected Plasmodium falciparum merozoite surface antigens in mild and cerebral malaria and associations with clinical outcomes.
    Mbengue B; Fall MM; Varela ML; Loucoubar C; Joos C; Fall B; Niang MS; Niang B; Mbow M; Dieye A; Perraut R
    Clin Exp Immunol; 2019 Apr; 196(1):86-96. PubMed ID: 30580455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breadth of anti-merozoite antibody responses is associated with the genetic diversity of asymptomatic Plasmodium falciparum infections and protection against clinical malaria.
    Rono J; Osier FH; Olsson D; Montgomery S; Mhoja L; Rooth I; Marsh K; Färnert A
    Clin Infect Dis; 2013 Nov; 57(10):1409-16. PubMed ID: 23983244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya.
    Polley SD; Conway DJ; Cavanagh DR; McBride JS; Lowe BS; Williams TN; Mwangi TW; Marsh K
    Vaccine; 2006 May; 24(19):4233-46. PubMed ID: 16111789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to polymorphic invasion-inhibitory and non-Inhibitory epitopes of Plasmodium falciparum apical membrane antigen 1 in human malaria.
    Mugyenyi CK; Elliott SR; McCallum FJ; Anders RF; Marsh K; Beeson JG
    PLoS One; 2013; 8(7):e68304. PubMed ID: 23861883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malaria.
    Osier FH; Feng G; Boyle MJ; Langer C; Zhou J; Richards JS; McCallum FJ; Reiling L; Jaworowski A; Anders RF; Marsh K; Beeson JG
    BMC Med; 2014 Jul; 12():108. PubMed ID: 24980799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Boosting antibody responses to Plasmodium falciparum merozoite antigens in children with highly seasonal exposure to infection.
    Akpogheneta OJ; Dunyo S; Pinder M; Conway DJ
    Parasite Immunol; 2010 Apr; 32(4):296-304. PubMed ID: 20398230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targets and Mechanisms Associated with Protection from Severe Plasmodium falciparum Malaria in Kenyan Children.
    Murungi LM; Sondén K; Llewellyn D; Rono J; Guleid F; Williams AR; Ogada E; Thairu A; Färnert A; Marsh K; Draper SJ; Osier FHA
    Infect Immun; 2016 Apr; 84(4):950-963. PubMed ID: 26787721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.